New tiotropium inhaler for COPD patients

Braltus uses the new Zonda inhaler to deliver the same dose of tiotropium as Spiriva HandiHaler for patients with COPD.

Braltus (tiotropium) is delivered using the Zonda inhaler.
Braltus (tiotropium) is delivered using the Zonda inhaler.

Braltus is indicated as a maintenance bronchodilator treatment to relieve symptoms in adults with COPD.

Each capsule contains 13 microgram tiotropium as powder for inhalation. Administered via the Zonda inhaler, Braltus provides the same 10 microgram delivered dose of tiotropium as the Spiriva HandiHaler.

Tiotropium is a long-acting anticholinergic and is well-established as a treatment for COPD.

Zonda inhaler

Zonda is a breath-actuated inhaler described by the manufacturer as 'ergonomic and compact'.

To operate, the inhaler is loaded with a Braltus capsule and a piercing button pressed to release the medication. When the patient breathes in, the capsule vibrates to confirm the rate of inhalation is sufficient. The capsules are clear so they also allow visual confirmation of dose delivery.

A new inhaler is supplied with every prescription of 30 Braltus capsules.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more